Product Registration in Africa: Building a Pipeline Instead of Chasing Approvals

Ask a struggling distributor about registration and you will hear about a file: one product, stuck at the authority, blocking a launch. Ask a market leader and you will hear about a pipeline: thirty files at different stages, four expected approvals this quarter, new submissions monthly. The difference in mindset explains most of the difference in results.

Sequence molecules by speed and value

Not all dossiers move at the same pace. Well-documented, long-established molecules with regional precedent clear faster than novel combinations. Open your pipeline with fast, high-volume registrations that fund the portfolio — then layer differentiated products whose longer reviews you can now afford to wait out.

File clean or don't file

African authorities are under-resourced and increasingly rigorous — a paradox that punishes sloppy submissions doubly, because a deficiency letter can add six months to a queue you already waited a year in. Zone IVb stability data, legalized administrative documents, and manufacturer credentials matching the dossier exactly are non-negotiable at submission, not corrections for later.

Regional harmonization is real — use it

The African Medicines Agency and regional harmonization initiatives (ZaZiBoNa in Southern Africa, the EAC joint-assessment procedure in the East) increasingly allow one strong dossier to open several markets. Structure your master dossier to harmonized standards from day one, and each new market becomes an adaptation rather than a rebuild.

A disciplined pipeline compounds: every approval strengthens your authority relationships, every clean file speeds the next review, and within three years you hold a registration portfolio competitors cannot replicate quickly at any price. In African pharmaceutical distribution, the registration pipeline is the moat.